GDUFA Research Outcomes
BE Methods and Analyses
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to bioequivalence methods and analyses for generic drug products.
-
Impact of Excipients on Drug Permeation to Support Biowaivers for Non-Q1/Q2 Products
Bode, Chris
-
Intestinal Influx Transporters: A Missing Piece in the Puzzle?
Zhang, Lei
-
Using PBPK Model to Support Risk Assessment for Oral Products
Wu, Fang
-
Challenges and Opportunities when Using Oral PBPK to Support Risk Assessment and Biowaiver in Regulatory Submissions
Wu, Fang
-
Regulatory and Scientific Considerations on Characterizations of Complex Polymeric Excipients
Wang, Yan
-
Bioequivalence Approaches for Long-Acting Drug Products: Regulatory and Scientific Considerations
Wang, Yan
-
Exploiting Dual Solid State PBPK Tools to Assess the Bio(in)equivalence of Tacrolimus Amorphous Formulations with Various Degrees of Crystallization Arising During Storage
Turner, David
-
PBPK Modeling of Supersaturating Drug Products
Turner, David
-
Reverse Translational Assessment of CYP450- and OATP-Mediated Clearance in Chronic Kidney Disease: from Clinical Data to PBPK Modeling
Tan, Ming-Liang
-
Alternative BE Approaches for Data Analysis Due To COVID-19 Related Study Interruptions
Gong, Yuqing